Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $43 from $31 and keeps an Equal Weight rating on the shares. The ...
In a report released on November 8, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a ...
Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...
Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...
The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...
Zacks.com on MSN6d
PTC to Report Q4 Earnings: Here's What Investors Should KnowPTC Inc. PTC is scheduled to report fourth-quarter fiscal 2024 results on Nov. 6.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.For the quarter, PTC anticipates revenues to ...
Hyperion Munitions produces an innovative enhancement for the AR-15’s mil-spec trigger design that allows for custom tuning ...
Fiscal '25 Constant Currency ARR Growth Guidance: 9% to 10%. PTC Inc (NASDAQ:PTC) reported a solid 25% year-over-year growth in free cash flow for fiscal 2024. The company achieved a 12% year-over ...
US-headquartered PTC, a global software company, is looking to raise its average annual investment of $70 million in India to ...
DREO, the No.1 fan & heater brand in the U.S., proudly unveils the MC706-a powerful 2-in-1 Tower Fan & Heater that brings ...
For the quarter, PTC anticipates revenues to be between $598 million and $648 million. Non-GAAP earnings per share (EPS) are expected to be between $1.30 and $1.66. The Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback